Results 141 to 150 of about 3,864 (165)

562: Elexacaftor/tezacaftor/ivacaftor in children aged 6 and older with cystic fibrosis and at least 1 F508del allele: Interim results from a Phase 3 open-label extension study

, 2021
Félix Ratjen, Hugo Murua Escobar, Jonathan M. Gaffin, Susanna A. McColley, Erica A. Roesch, Javier Padillo–Ruiz, Claire Wainwright, Neil Ahluwalia, Christopher Chu, Sabrina Noël, Samuel M. Moskowitz, David Waltz, Tanya G. Weinstock, Jane C. Davies   +13 more
openalex   +1 more source

259 A pilot study to evaluate the impact of the Patch Cap and Patch App on adherence to vitamins and elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis

, 2022
D. Willey-Courand, S. Kubes, H. Keyt, E. Ortiz   +3 more
openalex   +1 more source

Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis

Pulmonology, 2023
V. Fainardi, K. Skenderaj, A. Ciuni, S. Esposito, N. Sverzellati, G. Pisi   +5 more
doaj   +1 more source

570: Baseline lung disease before starting elexacaftor/tezacaftor/ivacaftor may predict treatment response

, 2021
Z. Holliday
openalex   +1 more source

137 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 2 and older with cystic fibrosis and at least one F508del allele: 48-week results of an open-label extension study

, 2023
Jennifer L. Goralski, Cori Daines, J. Pittman, Jonathan H. Rayment, P. Robinson, Rebecca Thursfield, Florian Stehling, F. Ratjen, N. Ahluwalia, Chenghao Chu, Prema R. Menon, T. Weinstock, Marcus Mall   +12 more
openalex   +1 more source

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

, 2023
Jennifer L. Goralski, Jordana E. Hoppe, Marcus Mall, Susanna A. McColley, Edward F. McKone, Bonnie Ramsey, Jonathan H. Rayment, Philip Robinson, Florian Stehling, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Neil Ahluwalia, Anna Chin, Chenghao Chu, Mengdi Lu, Tao Niu, Tanya G. Weinstock, Félix Ratjen, Margaret Rosenfeld   +18 more
openalex   +1 more source

38 Cutaneous rash with elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis

, 2022
J. Ma, K. Nandalike, S. Jhawar, R. Kamerman-Kretzmer, Yanhai Shi   +4 more
openalex   +1 more source

173 Effectiveness of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis: The pediatric PROMISE study

, 2022
F. Ratjen, J. Pittman, Amanda Paynter, M. Skalland, S. Heltshe, Jiaoe Xie, Leonard Couture, D. Nichols, S. Rowe, M. Rosenfeld   +9 more
openalex   +1 more source

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis:The Dutch National KOALA study [PDF]

, Akkerman, Onno, Gan, C. Tji, Hansen, Carina, Heijerman, Harry G.M., Hellemons, Merel E., Luijk, Bart, Steenhuis, Willie N., van der Meer, Renske, van der Vaart, Hester, van Gemert, Anna, Verkleij, Marieke, Verschuuren, Erik, Visser, Klara A.   +13 more
core   +1 more source

Utilisation of CFTR orthologues to evaluate new therapies for cystic fibrosis [PDF]

, 2022
Ng , Demi
core